The Neurocritical Care Research Network: NCRN
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Neurocritical care diseases carry a high morbidity and mortality. Therapeutic and technological advances in neurocritical care have greatly improved the outcome of a variety of life-threatening disorders including traumatic brain injury, acute ischemic stroke, intracerebral and subarachnoid hemorrhage, and anoxic injury following cardiac arrest. These advances have stemmed from a better understanding of the physiology of neurocritical care illnesses, improved neuromonitoring techniques, and the introduction of more efficacious treatments. Despite all the advances in neuromonitoring, diagnostic imaging, and emerging treatments, much research needs to be undertaken in neurocritical care. Many of the clinical trials carried out in the general critical care population have excluded neurocritical care patients. For instance, the landmark ARDSNET trial that demonstrated the beneficial effects of low tidal volume ventilation in patients with ARDS cannot be directly applied to neurocritical care patients who frequently may experience this pulmonary complication. There is a need for a more cohesive and integrated research system or network to establish a track record for high-quality, investigator-initiated clinical research in neurocritical care. Such a system may help us overcome potential impediments to the future advancement of neurocritical care research. We propose the creation of the neurocritical care research network. The mission of the Network is to facilitate multicenter and multidisciplinary collaboration and patient enrollment in clinical trials of specific neurocritical care diseases.
- Smith M. Neurocritical care; has it come of age? B J Anaesthesia. 2004;93:753–5. CrossRef
- Bleck T. Critical care and emergency neurology. In: Cohen MM, editor. The American academy of neurology: The first 50 years 1948–1998. St Paul: American Academy of Neurology; 1998. pp. 225–7.
- www.neurocriticalcare.org. Accessed 1 June 2010.
- Mayer SA, Coplin WM, Chang C, et al. Program requirements for fellowship training in neurological intensive care: United Council for Neurologic Subspecialties guidelines. Neurocritical Care. 2006;5:166–71. CrossRef
- Mayer SA, Coplin WM, Chang C, et al. Core curriculum and competencies for advanced training in neurological intensive care: United Council for Neurologic Subspecialties guidelines. Neurocritical Care. 2006;5:159–65. CrossRef
- www.ardsnet.org. Accessed 1 June 2010.
- www.anzics.com.au/ctg. Accessed 1 June 2010.
- www.ccctg.ca. Accessed 1 June 2010.
- The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–8. CrossRef
- The National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–75. CrossRef
- The National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671–84. CrossRef
- Cook DJ, Guyatt GH, Marshall J, et al., for the Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338:791–7.
- Sandham JD, Hull RD, Brant RF, et al., for the Canadian Critical Care Trials Group. A randomised controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients N Engl J Med. 2003;38:5–14.
- Cook DJ, Rocker G, Marshall J, et al., for the Level of Care Study Investigators and the Canadian Critical Care Trials Group. Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med. 2003;349:1123–32.
- Hutchison SJ, Ward RE, Lacroix J, et al., for the Hypothermia Pediatric Head Injury Trial investigators and the Canadian Critical Care Trials Group. Hypothermia Therapy Following Traumatic Brain Injury in Children. N Engl J Med. 2008;358:2447–56.
- Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356:2139–43. CrossRef
- The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56. CrossRef
- The MERIT Study Investigators. Introduction of the medical emergency team (MET) system: a cluster-randomised controlled trial. Lancet. 2005;365:2091–7. CrossRef
- The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7. CrossRef
- Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:557–63. CrossRef
- Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557–63. CrossRef
- Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619–24. CrossRef
- Pickard JD, Murray GD, Illingwoth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636–42. CrossRef
- Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37. CrossRef
- Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.
- Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg. 1991;75:731–9. CrossRef
- http://www.nett.umich.edu/nett/welcome. Accessed 1 June 2010.
- Wright WL. Mapping neurocritical care units. Curr Neurocritical Care Soc Newslett. 2007;2(3):4.
- http://www.hhs.gov/ohrp/humansubjects/guidance/hsdc97-01.htm. Accessed 1 June 2010.
- http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.24. Accessed 8 June 2010.
- http://www.neurocriticalcare.org/i4a/pages/index.cfm?pageid=3961. Accessed 8 June 2010.
- The Neurocritical Care Research Network: NCRN
Volume 16, Issue 1 , pp 29-34
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press Inc
- Additional Links
- Neurocritical care
- Critical care
- Clinical trials
- Research network
- Industry Sectors
- Author Affiliations
- 1. Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 6501 Fannin St, MS:NB320, Houston, TX, 77030, USA
- 2. Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
- 3. Department of Neurology, UT Southwestern University, Dallas, TX, USA
- 4. Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, USA
- 5. Department of Neurology, Stanford University, Palo Alto, CA, USA
- 6. Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, USA